NL-OMON47934已完成3 期
Simvastatin addition to improve symptoms, cognition, metabolic syndrome and movement disorders in patients with recent-onset psychotic disorder. - Simvastatin in patients with recent-onset schizophrenia.
niversitair Medisch Centrum Utrecht0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •A DSM-IV-R diagnosis of: 295.x (schizophrenia, schizophreniform disorder, or schizoaffective disorder) or 298.9 (psychosis NOS);
- •Onset of first psychosis no longer than 3 years ago;
- •Age between 18 and 50 years;
- •Written informed consent is obtained;
- •Female patients of childbearing potential need to utilize a proper method of contraception (the pill, vaginal ring, hormonal patch, intrauterine device, cervical cape, condom, contraceptive injection, diaphragm) in case of sexual intercourse during the study.
排除标准
- •Fulfilment of criteria for statin prescription; according to the Dutch Heart Foundation (Hartstichting), statin treatment is indicated when the total cholesterol level is > 8 mmol/l (www.hartstichting.nl);
- •Presence of any of the contra-indications or warnings for the use of simvastatin as reported in the SPC;
- •Chronic use of glucocorticosteroids (temporary use is permitted, if stopped at least 1 month before start of treatment trial);
- •Chronic use of non-steroidal anti-inflammatory drugs (temporary use is permitted, if stopped at least 1 month before start of treatment trial);
- •Current use of statins or other lipid-lowering drugs (temporary use is permitted, if stopped at least 1 month before start of treatment trial);
- •Pregnancy or breast-feeding (urine pregnancy test will be performed for sexually active females with child bearing potential);
- •In case of familial risk for muscular disorders or previously experienced muscle toxicity when taking medication similar to simvastatin, creatine kinase (CK) levels will also be checked (as recommended by the Dutch Farmacotherapeutisch Kompas, www.farmacotherapeutischkompas.nl/);
- •In addition, levels of aspartate (ASAT), alanine aminotransferase (ALAT), gamma-glutamyltranspeptidase (gamma-GT) and creatinine will be checked when a history of alcohol abuse, liver or kidney disorders is reported based as recommended by the Dutch Farmacotherapeutisch Kompas, www.farmacotherapeutischkompas.nl/);
- •Use of comedication that either inhibits or induces the live enzyme CYP3A4 which is responsible for the degradation of simvastatin. Inhibitors of CYP3A4 include itraconazole, ketoconazole, posaconazole, fluconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, telaprevir, boceprevir, imatinib, ticagrelor, voriconazole; inducers of CYP3A4 include carbamazepine, efavirenz, nevirapin, etravirin (can be washed out before start of trial);
- •Use of comedication that may increase the risk for myalgia, rhabdomyolyse and myopathy, including colchicine, bosentan, fenobarbital, fenytoin, hypericum, rifabutin, rifampicin, fibrates (e.g. gemfibrozil), fusidic acid, carbamazepine (can be washed out before start of trial). The MRI scan requires additional exclusion criteria to be eligible to participate in this part of the study (if these additional criteria are met, patients can participate in the study but not in the MRI component): Ferrous objects in or around the body (e.g. braces, glasses, pacemaker, metal fragments) Claustrophobia
研究者
相似试验
进行中（未招募）
1 期
The effect of simvastatin addition to improve symptoms, mental abilities and metabolic syndrome in patients with recent-onset schizophrenia.Schizophrenia, schizoaffective or schizophreniform disorder (DSM-IV 295.*) or psychosis NOS (not otherwise specified) (298.9)EUCTR2013-000834-36-NLniversity Medical Center Utrecht250
已完成
3 期
Simvastatine in the treatment of schizophreniaschizophrenia.schizophreniaIRCT201410021556N65Tehran University of Medical Sciences50
进行中（未招募）
不适用
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidEUCTR2011-004361-32-DEPhilipps-Universität Marburg
进行中（未招募）
2 期
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidA prospective multi-centre randomised double-blind placebo-controlled pilot studyL12.0Bullous pemphigoidDRKS00003851Philipps-Universität Marburg1
进行中（未招募）
1 期
RETRO-PRO: The effectiveness of simvastatin compared to atorvastatin: an e-clinical randomised trial within a research database in routine clinical practice - a feasibility study - RCTs within the database: a feasibility study of statin effectivenesssubjects who in the opinion of the GP investigator would require a statin for primary prevention according to the 2008 NICE guideline on lipid modification: adults over 40 who have a 20% or greater 10-risk of developing cardiovascular disease.EUCTR2009-014913-28-GBondon School of Hygiene & Tropical Medicine300